Clinical Trials Browser

Phase 2 × ivosidenib × Tumor-Agnostic × Clear all

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT06593548 2024-09-19

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

Phase 2 Not yet recruiting

Neoplasm Metastasis